CAB39L and neoplasm: In keeping with in vitro results, BGC823 xenografts with ectopic CAB39L expression demonstrated a significant reduction in both tumor size and weight (Fig. 3e1–2), with western blot confirming the ectopic expression of CAB39L (Fig. 3e3).